| Dishman Pharmaceuticals and Chemicals Ltd(Merged) |
|---|
| Registered Office: Bhadr-Raj Chambers,Swastik Cross Road Navrangpura,Ahmedabad-380009, Gujarat |
| Tel. No: 91-79-26443053/26445807 |
| Fax No: 91-79-26420198 |
| Email: dishman@dishmangroup.com |
| Website: www.dishmangroup.com |
| Public issue of 3433500 equity shares of Rs.10 each at a price of Rs. 175 per share for cash aggregating Rs. 60.09 crore (referred to as the "Issue"). Issue would constitute 25% of the fully diluted post issue paid-up capital of the company. |
| Issue | Money Payable On | ||
|---|---|---|---|
| Opens On | Closes On | Application | Allotment |
| 29-Mar-2004 | 07-Apr-2004 | ₹175.00 - 0.00 | ₹0.00 - 0.00 |
| Minimum Application for shares in Nos : 50 | Further Multiples of :50 |
|---|
| (₹ Cr) | Lead Managers to the Issue | |
|---|---|---|
| Project Cost | 0.00 | Enam Financial Consultants Pvt Ltd |
| Project Financed through Current Offer | 60.09 | IL&FS Investsmart Ltd |
| Post Issue Equity Share Capital | 13.73 | |
| Issue Price | 175.00 |
| Projects |
|---|
| Setting-up API & Intermediate manufacturing plant |
| Setting-up of a dedicated R&D center |
| Promoted By |
|---|
| Janmejay R Vyas |
| Listing At |
|---|
| BSE |
| NSE |
| Registrar To The Issue |
|---|